Annex VI to Clinical Trial Regulation

Annex VI to Clinical Trial Regulation 536/2014 Risk assessment-based concept of an interim* solution on expiry date labelling of the immediate packaging of Investigational Medicinal Products (IMPs) dated 02-Mar-2021